Prostate-specific membrane antigen theranostics in advanced prostate cancer: an evolving option.
Nikhil MayorNiranjan Jude SathianathenJames ButeauSamantha KoschelMarta Antón JuanillaJada KapoorArun AzadMichael S HofmanDeclan G MurphyPublished in: BJU international (2020)
PSMA RLT is a promising new treatment option for men with mCPRC, and may also have utility in less advanced prostate cancer.